Big Pharma activity eyed in mobile trends

The life sciences industry could drive at least a couple trends this year in the mobile tech arena, according to mobihealthnews. In a roundup of a dozen trends to watch this year, the publication says the FDA could publish guidelines on how medical device regulations are translated into the realm of mobile devices such as smartphones and tablets. Also, mobile tech is expected to aid pharma groups in the areas of advertising, clinical development (such as Pfizer's ($PFE) eclinical trial) and getting patients to take their meds as prescribed, according to mobihealthnews. Article

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.